Search

Your search keyword '"Wheeler, Allison P"' showing total 254 results
Start Over Author "Wheeler, Allison P"
254 results on '"Wheeler, Allison P"'

1. Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet components.

Author

Wheeler, Allison, Snyder, Edward, Refaai, Majed, Cohn, Claudia, Poisson, Jessica, Fontaine, Magali, Sehl, Mary, Nooka, Ajay, Uhl, Lynne, Spinella, Philip, Fenelus, Maly, Liles, Darla, Coyle, Thomas, Becker, Joanne, Jeng, Michael, Gehrie, Eric, Spencer, Bryan, Young, Pampee, Johnson, Andrew, OBrien, Jennifer, Schiller, Gary, Roback, John, Malynn, Elizabeth, Jackups, Ronald, Avecilla, Scott, Liu, Kathy, Bentow, Stanley, Varrone, Jeanne, Benjamin, Richard, and Corash, Laurence

Subjects
Humans, Platelet Transfusion, Female, Middle Aged, Male, Aged, Acute Lung Injury, Blood Platelets, Prospective Studies, Adult, Thrombocytopenia, Hematologic Diseases
Abstract

Patients treated with antineoplastic therapy often develop thrombocytopenia requiring platelet transfusion, which has potential to exacerbate pulmonary injury. This study tested the hypothesis that amotosalen-UVA pathogen-reduced platelet components (PRPCs) do not potentiate pulmonary dysfunction compared with conventional platelet components (CPCs). A prospective, multicenter, open-label, sequential cohort study evaluated the incidence of treatment-emergent assisted mechanical ventilation initiated for pulmonary dysfunction (TEAMV-PD). The first cohort received CPC. After the CPC cohort, each site enrolled a second cohort transfused with PRPC. Other outcomes included clinically significant pulmonary adverse events (CSPAE) and the incidence of treatment-emergent acute respiratory distress syndrome (TEARDS) diagnosed by blinded expert adjudication. The incidence of TEAMV-PD in all patients (1068 PRPC and 1223 CPC) was less for PRPC (1.7 %) than CPC (3.1%) with a treatment difference of -1.5% (95% confidence interval [CI], -2.7 to -0.2). In patients requiring ≥2 PCs, the incidence of TEAMV-PD was reduced for PRPC recipients compared with CPC recipients (treatment difference, -2.4%; 95% CI, -4.2 to -0.6). CSPAE increased with increasing PC exposure but were not significantly different between the cohorts. For patients receiving ≥2 platelet transfusions, TEARDS occurred in 1.3% PRPC and 2.6% CPC recipients (P = .086). Bayesian analysis demonstrated PRPC may be superior in reducing TEAMV-PD and TEARDS for platelet transfusion recipients compared with CPC recipients, with 99.2% and 88.8% probability, respectively. In this study, PRPC compared with CPC demonstrated high probability of reduced severe pulmonary injury requiring assisted mechanical ventilation in patients with hematology disorders dependent on platelet transfusion. This trial was registered at www.ClinicalTrials.gov as #NCT02549222.

Published
2024

2. The Diagnostic Landscape of Adult Neurogenetic Disorders.

Author

Waung, Maggie, Ma, Fion, Wheeler, Allison, Zai, Clement, and So, Joyce

Subjects
adult-onset, complex neurological disease, genetic analysis, neurogenetic disease, next generation sequencing, personalized medicine, whole exome sequencing, whole genome sequencing
Abstract

Neurogenetic diseases affect individuals across the lifespan, but accurate diagnosis remains elusive for many patients. Adults with neurogenetic disorders often undergo a long diagnostic odyssey, with multiple specialist evaluations and countless investigations without a satisfactory diagnostic outcome. Reasons for these diagnostic challenges include: (1) clinical features of neurogenetic syndromes are diverse and under-recognized, particularly those of adult-onset, (2) neurogenetic syndromes may manifest with symptoms that span multiple neurological and medical subspecialties, and (3) a positive family history may not be present or readily apparent. Furthermore, there is a large gap in the understanding of how to apply genetic diagnostic tools in adult patients, as most of the published literature focuses on the pediatric population. Despite these challenges, accurate genetic diagnosis is imperative to provide affected individuals and their families guidance on prognosis, recurrence risk, and, for an increasing number of disorders, offer targeted treatment. Here, we provide a framework for recognizing adult neurogenetic syndromes, describe the current diagnostic approach, and highlight studies using next-generation sequencing in different neurological disease cohorts. We also discuss diagnostic pitfalls, barriers to achieving a definitive diagnosis, and emerging technology that may increase the diagnostic yield of testing.

Published
2023

3. Representation of Authors by Gender, Race, and Ethnicity in Pathology Clinical Practice Guidelines

Author

Martin, Amarilis A., Walker, Shannon C., Wheeler, Allison P., Jacobs, Jeremy W., Booth, Garrett S., and Silver, Julie K.

Subjects
United States. Census Bureau, Minorities, Medicine -- Practice, Practice guidelines (Medicine), Medical societies, Medical colleges, Health, College of American Pathologists
Abstract

* Context.--United States' clinical practice guidelines (CPGs) are often produced by professional societies and used worldwide in daily medical practice. However, studies in various medical specialties demonstrate under-representation of women and racial and ethnic minority groups in CPGs. The representation of authors by gender, race, and ethnicity of US pathology CPGs has not been previously evaluated. Objective.--To assess if women and individuals from racial and ethnic minority groups are underrepresented as authors of pathology CPGs. Design.--The gender, race, ethnicity, and terminal degrees of authors of 18 CPGs from the College of American Pathologists were coded by using photographs and other available information online and compared to their representation in academic pathology per Association of American Medical Colleges benchmark data. Results.--Two hundred seventy-five author positions (202 physician author positions) were analyzed. Women overall (119 of 275; 43.3%) and women physicians (65 of 202; 32.2%) held fewer positions than all men and men physicians. Women physicians were significantly underrepresented in physician author positions, while White men physicians were significantly overrepresented in all, first, senior, and corresponding authorship roles when compared to the proportion of women and White men physicians among pathology faculty, respectively. Asian men and women physicians were underrepresented as compared to their representation among pathology faculty. Conclusions.--Men, particularly White men physicians, are overrepresented among pathology CPG author positions, while women physicians and some physicians from racial and ethnic minority groups are underrepresented. Further research is needed to understand the impact of these findings on the careers of underrepresented physicians and the content of guidelines. (Arch Pathol Lab Med. 2024;148:230-241; doi: 10.5858/arpa.2022-0351-OA), Clinical practice guidelines (CPGs) influence the daily practice of medicine. In the United States, guidelines are often produced by professional societies and used around the world. As such, they have [...]

Published
2024
Full Text
View/download PDF

4. Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial

Author

Chowdary, Pratima, Angchaisuksiri, Pantep, Apte, Shashikant, Astermark, Jan, Benson, Gary, Chan, Anthony K C, Jiménez Yuste, Victor, Matsushita, Tadashi, Høgh Nielsen, Amalie Rhode, Sathar, Jameela, Sutton, Christopher, Šaulytė Trakymienė, Sonata, Tran, Huyen, Villarreal Martinez, Laura, Wheeler, Allison P, Windyga, Jerzy, Young, Guy, Thaung Zaw, Jay Jay, and Eichler, Hermann

Published
2024
Full Text
View/download PDF

5. Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components

Author

Snyder, Edward L, Wheeler, Allison P, Refaai, Majed, Cohn, Claudia S, Poisson, Jessica, Fontaine, Magali, Sehl, Mary, Nooka, Ajay K, Uhl, Lynne, Spinella, Philip, Fenelus, Maly, Liles, Darla, Coyle, Thomas, Becker, Joanne, Jeng, Michael, Gehrie, Eric A, Spencer, Bryan R, Young, Pampee, Johnson, Andrew, O'Brien, Jennifer J, Schiller, Gary J, Roback, John D, Malynn, Elizabeth, Jackups, Ronald, Avecilla, Scott T, Lin, Jin‐Sying, Liu, Kathy, Bentow, Stanley, Peng, Ho‐Lan, Varrone, Jeanne, Benjamin, Richard J, and Corash, Laurence M

Subjects
Clinical Research, Lung, Acute Respiratory Distress Syndrome, Rare Diseases, Hematology, Patient Safety, Respiratory, Good Health and Well Being, Blood Platelets, Blood Transfusion, Cohort Studies, Humans, Photosensitizing Agents, Platelet Transfusion, Respiratory Distress Syndrome, Transfusion Reaction, assisted mechanical ventilation, pathogen reduction, platelet transfusion, pulmonary adverse events, Cardiorespiratory Medicine and Haematology, Clinical Sciences, Immunology, Cardiovascular System & Hematology
Abstract

BackgroundPlatelet transfusion carries risk of transfusion-transmitted infection (TTI). Pathogen reduction of platelet components (PRPC) is designed to reduce TTI. Pulmonary adverse events (AEs), including transfusion-related acute lung injury and acute respiratory distress syndrome (ARDS) occur with platelet transfusion.Study designAn open label, sequential cohort study of transfusion-dependent hematology-oncology patients was conducted to compare pulmonary safety of PRPC with conventional PC (CPC). The primary outcome was the incidence of treatment-emergent assisted mechanical ventilation (TEAMV) by non-inferiority. Secondary outcomes included: time to TEAMV, ARDS, pulmonary AEs, peri-transfusion AE, hemorrhagic AE, transfusion reactions (TRs), PC and red blood cell (RBC) use, and mortality.ResultsBy modified intent-to-treat (mITT), 1068 patients received 5277 PRPC and 1223 patients received 5487 CPC. The cohorts had similar demographics, primary disease, and primary therapy. PRPC were non-inferior to CPC for TEAMV (treatment difference -1.7%, 95% CI: (-3.3% to -0.1%); odds ratio = 0.53, 95% CI: (0.30, 0.94). The cumulative incidence of TEAMV for PRPC (2.9%) was significantly less than CPC (4.6%, p = .039). The incidence of ARDS was less, but not significantly different, for PRPC (1.0% vs. 1.8%, p = .151; odds ratio = 0.57, 95% CI: (0.27, 1.18). AE, pulmonary AE, and mortality were not different between cohorts. TRs were similar for PRPC and CPC (8.3% vs. 9.7%, p = .256); and allergic TR were significantly less with PRPC (p = .006). PC and RBC use were not increased with PRPC.DiscussionPRPC demonstrated reduced TEAMV with no excess treatment-related pulmonary morbidity.

Published
2022

7. Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial

Author

Castaman, Giancarlo, Crary, Shelley E, Escobar, Miguel, Gomez, Esteban, Haley, Kristina M, Hermans, Cedric R J R, Kampmann, Peter, Kazmi, Rashid, Key, Nigel S, Klamroth, Robert, Konkle, Barbara A, Kruse-Jarres, Rebecca, Lattimore, Susan, Lemons, Richard, Meijer, Karina, O'Connell, Niamh, Quon, Doris V, Raheja, Priyanka, Symington, Emily, Verhamme, Peter, Visweshwar, Nathan, von Drygalski, Annette, Wang, Michael, Wheeler, Allison P, White, Shanna, Young, Guy, Coppens, Michiel, Pipe, Steven W, Miesbach, Wolfgang, Astermark, Jan, Recht, Michael, van der Valk, Paul, Ewenstein, Bruce, Pinachyan, Karen, Galante, Nicholas, Le Quellec, Sandra, Monahan, Paul E, and Leebeek, Frank W G

Published
2024
Full Text
View/download PDF

8. Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial

Author

Ragni, Margaret V, Rothenberger, Scott D, Feldman, Robert, Nance, Danielle, Leavitt, Andrew D, Malec, Lynn, Kulkarni, Roshni, Sidonio, Robert, Jr, Kraut, Eric, Lasky, Joseph, Pruthi, Rajiv, Angelini, Dana, Philipp, Claire, Hwang, Nina, Wheeler, Allison P, Seaman, Craig, Machin, Nicoletta, Xavier, Frederico, Meyer, Michael, Bellissimo, Daniel, Humphreys, Gregory, Smith, Kenneth J, Merricks, Elizabeth P, Nichols, Timothy C, Ivanco, Dana, Vehec, Deborah, Koerbel, Glory, and Althouse, Andrew D

Published
2023
Full Text
View/download PDF

10. Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial

Author

Self, Wesley H., Wheeler, Allison P., Stewart, Thomas G., Schrager, Harry, Mallada, Jason, Thomas, Christopher B., Cataldo, Vince D., O’Neal, Hollis R., Jr., Shapiro, Nathan I., Higgins, Conor, Ginde, Adit A., Chauhan, Lakshmi, Johnson, Nicholas J., Henning, Daniel J., Jaiswal, Stuti J., Mammen, Manoj J., Harris, Estelle S., Pannu, Sonal R., Laguio-Vila, Maryrose, El Atrouni, Wissam, de Wit, Marjolein, Hoda, Daanish, Cohn, Claudia S., McWilliams, Carla, Shanholtz, Carl, Jones, Alan E., Raval, Jay S., Mucha, Simon, Ipe, Tina S., Qiao, Xian, Schrantz, Stephen J., Shenoy, Aarthi, Fremont, Richard D., Brady, Eric J., Carnahan, Robert H., Chappell, James D., Crowe, James E., Jr., Denison, Mark R., Gilchuk, Pavlo, Stevens, Laura J., Sutton, Rachel E., Thomsen, Isaac, Yoder, Sandra M., Bistran-Hall, Amanda J., Casey, Jonathan D., Lindsell, Christopher J., Wang, Li, Pulley, Jill M., Rhoads, Jillian P., Bernard, Gordon R., and Rice, Todd W.

Published
2022
Full Text
View/download PDF

13. Standardized two-step testing of antibody activity in COVID-19 convalescent plasma

Author

Gilchuk, Pavlo, Thomsen, Isaac, Yoder, Sandra, Brady, Eric, Chappell, James D., Stevens, Laura J., Denison, Mark R., Sutton, Rachel E., Chen, Rita E., VanBlargan, Laura A., Suryadevara, Naveenchandra, Zost, Seth J., Schmitz, Jonathan, Pulley, Jill M., Diamond, Michael S., Rhoads, Jillian P., Bernard, Gordon R., Self, Wesley H., Rice, Todd W., Wheeler, Allison P., Crowe, James E., Jr., and Carnahan, Robert H.

Published
2022
Full Text
View/download PDF

21. Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial

Author

Coppens, Michiel, primary, Pipe, Steven W, additional, Miesbach, Wolfgang, additional, Astermark, Jan, additional, Recht, Michael, additional, van der Valk, Paul, additional, Ewenstein, Bruce, additional, Pinachyan, Karen, additional, Galante, Nicholas, additional, Le Quellec, Sandra, additional, Monahan, Paul E, additional, Leebeek, Frank W G, additional, Castaman, Giancarlo, additional, Crary, Shelley E, additional, Escobar, Miguel, additional, Gomez, Esteban, additional, Haley, Kristina M, additional, Hermans, Cedric R J R, additional, Kampmann, Peter, additional, Kazmi, Rashid, additional, Key, Nigel S, additional, Klamroth, Robert, additional, Konkle, Barbara A, additional, Kruse-Jarres, Rebecca, additional, Lattimore, Susan, additional, Lemons, Richard, additional, Meijer, Karina, additional, O'Connell, Niamh, additional, Quon, Doris V, additional, Raheja, Priyanka, additional, Symington, Emily, additional, Verhamme, Peter, additional, Visweshwar, Nathan, additional, von Drygalski, Annette, additional, Wang, Michael, additional, Wheeler, Allison P, additional, White, Shanna, additional, and Young, Guy, additional

Published
2024
Full Text
View/download PDF

22. Gender composition and geographical representation of American Society of Hematology clinical practice guideline authors

Author

Jacobs, Jeremy W, primary, Martin, Amarilis A, additional, Stephens, Laura D, additional, Adkins, Brian D, additional, Woo, Jennifer S, additional, Sharma, Deva, additional, Wheeler, Allison P, additional, Glover, Raeshun T, additional, Yui, Jennifer C, additional, Walker, Shannon C, additional, Khan, Shazia S, additional, Booth, Garrett S, additional, and Silver, Julie K, additional

Published
2024
Full Text
View/download PDF

30. Treatment practices and response in Kaposiform hemangioendothelioma: a multi-center cohort study

Author

Borst, Alexandra, primary, Eng, Whitney, additional, Griffin, Morgan, additional, Ricci, Kiersten, additional, Engel, Elissa, additional, Adams, Denise, additional, Dayneka, Jillian, additional, Cohen-Cutler, Sally J., additional, Andreoli, Steven M., additional, Wu, Melinda D., additional, Wheeler, Allison P., additional, Heym, Kenneth, additional, Crary, Shelley, additional, Nakano, Taizo, additional, Schulte, Rachael, additional, Setty, Bhuvana, additional, McLean, Thomas, additional, Pahl, Kristy S., additional, Intzes, Stefanos, additional, Pateva, Irina, additional, Teitelbaum, Max, additional, Zong, Zili, additional, Li, Yimei, additional, and Jeng, Michael, additional

Published
2023
Full Text
View/download PDF

34. Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic review.

Author

Jacobs, Jeremy W., Sharma, Deva, Stephens, Laura D., Figueroa Villalba, Cristina A., Rinder, Henry M., Woo, Jennifer S., Wheeler, Allison P., Gerberi, Dana, Goel, Ruchika, Tormey, Christopher A., Booth, Garrett S., Bloch, Evan M., and Adkins, Brian D.

Subjects
BLOOD viscosity, HEMOGLOBINS, THROMBOSIS, PREGNANT women, THROMBOEMBOLISM
Abstract

Summary: The thrombotic risk with haemoglobin C trait (HbAC) or haemoglobin C disease (HbCC) is unclear. However, individuals with HbCC have demonstrated chronic haemolysis, higher blood viscosity and altered rheology when compared to individuals with wild‐type haemoglobin (HbAA). These physiological alterations may theoretically translate to increased risk of thrombosis; therefore, a systematic literature review was performed to investigate the possible association between HbAC and/or HbCC and thrombosis. Twenty‐two studies met inclusion criteria representing 782 individuals with HbAC (n = 694) or HbCC (n = 88). Fifteen studies described the presence/absence of venous thromboembolism (VTE) in patients with HbAC (n = 685) or HbCC (n = 79), while seven studies described patients with HbAC (n = 9) or HbCC (n = 9) and arterial thrombosis. Most (n = 20) studies were case reports or case series; however, two studies suggested a potential increased VTE risk with HbAC compared to HbAA in (i) all patients (OR 2.2, 95% CI: 0.9–5.5) and in (ii) pregnant individuals (RR 3.7, 95% CI 0.9–16). This review is the largest assessment of patients with HbC trait or disease and thrombosis to date; despite its limitations, the findings suggest HbC may be a predisposing risk factor to thrombosis. Prospective cohort studies are warranted to definitively elucidate the risk of thrombosis in this population. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

35. Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study.

Author

Borst, Alexandra J., Eng, Whitney, Griffin, Morgan, Ricci, Kiersten W., Engel, Elissa, Adams, Denise M., Dayneka, Jillian, Cohen‐Cutler, Sally J., Andreoli, Steven M., Wu, Melinda D., Wheeler, Allison P., Heym, Kenneth M., Crary, Shelley E., Nakano, Taizo A., Schulte, Rachael R., Setty, Bhuvana A., McLean, Thomas W., Pahl, Kristy S., Intzes, Stefanos, and Pateva, Irina

Published
2024
Full Text
View/download PDF

39. Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

Author

Poli Van Creveldkliniek Medisch, Pipe, Steven W, Leebeek, Frank W G, Recht, Michael, Key, Nigel S, Castaman, Giancarlo, Miesbach, Wolfgang, Lattimore, Susan, Peerlinck, Kathelijne, Van der Valk, Paul, Coppens, Michiel, Kampmann, Peter, Meijer, Karina, O'Connell, Niamh, Pasi, K John, Hart, Daniel P, Kazmi, Rashid, Astermark, Jan, Hermans, Cedric R J R, Klamroth, Robert, Lemons, Richard, Visweshwar, Nathan, von Drygalski, Annette, Young, Guy, Crary, Shelley E, Escobar, Miguel, Gomez, Esteban, Kruse-Jarres, Rebecca, Quon, Doris V, Symington, Emily, Wang, Michael, Wheeler, Allison P, Gut, Robert, Liu, Ying P, Dolmetsch, Ricardo E, Cooper, David L, Li, Yanyan, Goldstein, Brahm, Monahan, Paul E, Poli Van Creveldkliniek Medisch, Pipe, Steven W, Leebeek, Frank W G, Recht, Michael, Key, Nigel S, Castaman, Giancarlo, Miesbach, Wolfgang, Lattimore, Susan, Peerlinck, Kathelijne, Van der Valk, Paul, Coppens, Michiel, Kampmann, Peter, Meijer, Karina, O'Connell, Niamh, Pasi, K John, Hart, Daniel P, Kazmi, Rashid, Astermark, Jan, Hermans, Cedric R J R, Klamroth, Robert, Lemons, Richard, Visweshwar, Nathan, von Drygalski, Annette, Young, Guy, Crary, Shelley E, Escobar, Miguel, Gomez, Esteban, Kruse-Jarres, Rebecca, Quon, Doris V, Symington, Emily, Wang, Michael, Wheeler, Allison P, Gut, Robert, Liu, Ying P, Dolmetsch, Ricardo E, Cooper, David L, Li, Yanyan, Goldstein, Brahm, and Monahan, Paul E

Published
2023

41. Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

Author

Pipe, Steven W., primary, Leebeek, Frank W.G., additional, Recht, Michael, additional, Key, Nigel S., additional, Castaman, Giancarlo, additional, Miesbach, Wolfgang, additional, Lattimore, Susan, additional, Peerlinck, Kathelijne, additional, Van der Valk, Paul, additional, Coppens, Michiel, additional, Kampmann, Peter, additional, Meijer, Karina, additional, O’Connell, Niamh, additional, Pasi, K. John, additional, Hart, Daniel P., additional, Kazmi, Rashid, additional, Astermark, Jan, additional, Hermans, Cedric R.J.R., additional, Klamroth, Robert, additional, Lemons, Richard, additional, Visweshwar, Nathan, additional, von Drygalski, Annette, additional, Young, Guy, additional, Crary, Shelley E., additional, Escobar, Miguel, additional, Gomez, Esteban, additional, Kruse-Jarres, Rebecca, additional, Quon, Doris V., additional, Symington, Emily, additional, Wang, Michael, additional, Wheeler, Allison P., additional, Gut, Robert, additional, Liu, Ying P., additional, Dolmetsch, Ricardo E., additional, Cooper, David L., additional, Li, Yanyan, additional, Goldstein, Brahm, additional, and Monahan, Paul E., additional

Published
2023
Full Text
View/download PDF

43. Multicenter, Randomized Crossover Trial Comparing Recombinant Von Willebrand Factor and Tranexamic Acid for Heavy Menstrual Bleeding in Von Willebrand Disease

Author

Ragni, Margaret V., primary, Rothenberger, Scott, additional, Feldman, Robert, additional, Nance, Danielle, additional, Leavitt, Andrew D, additional, Malec, Lynn, additional, Sidonio, Jr., Robert F., additional, Kraut, Eric H., additional, Lasky, Joseph L, additional, Philipp, Claire S., additional, Angelini, Dana E., additional, Pruthi, Rajiv K., additional, Hwang, Nina, additional, Wheeler, Allison P., additional, Kulkarni, Roshni, additional, Seaman, Craig D., additional, Xavier, Frederico, additional, Machin, Nicoletta C, additional, Meyer, Michael, additional, Bellissimo, Daniel, additional, Smith, Kenneth J., additional, Merricks, Elizabeth P., additional, Nichols, Timothy C., additional, Ivanco, Dana, additional, Vehec, Deborah, additional, Koerbel, Glory, additional, and Althouse, Andrew D., additional

Published
2022
Full Text
View/download PDF

44. Response

Author

Self, Wesley H., primary, Wheeler, Allison P., additional, Chappell, James D., additional, Thomsen, Isaac, additional, Pulley, Jill M., additional, Rhoads, Jillian P., additional, Bernard, Gordon R., additional, and Rice, Todd W., additional

Published
2022
Full Text
View/download PDF

45. Contributors

Author

Abdel-Wahab, Omar, primary, Abrahm, Janet L., additional, Adams, Sharon, additional, Adewoye, Adeboye H., additional, Allen, Carl, additional, Ambinder, Richard F., additional, Anasetti, Claudio, additional, Anastasi, John, additional, Anderson, Julia A., additional, Antin, Joseph H., additional, Antony, Aśok C., additional, Araten, David J., additional, Armand, Philippe, additional, Armstrong, Gillian, additional, Armstrong, Scott A., additional, Arnold, Donald M., additional, Artz, Andrew S., additional, Awan, Farrukh T., additional, Baglin, Trevor P., additional, Benson, Don M., additional, Benz, Edward J., additional, Berliner, Nancy, additional, Bhagat, Govind, additional, Bhardwaj, Nina, additional, Bhatia, Ravi, additional, Bhatia, Smita, additional, Bhatt, Mihir D., additional, Bhatt, Vijaya Raj, additional, Bitan, Menachem, additional, Blinderman, Craig D., additional, Bollard, Catherine M., additional, Braun, Benjamin S., additional, Brenner, Malcolm K., additional, Brittenham, Gary M., additional, Brodsky, Robert A., additional, Brown, Myles, additional, Broxmeyer, Hal E., additional, Brummel-Ziedins, Kathleen, additional, Brunner, Andrew M., additional, Buadi, Francis K., additional, Burkhardt, Birgit, additional, Burns, Melissa, additional, Byrd, John C., additional, Caimi, Paolo F., additional, Caligiuri, Michael A., additional, Canavan, Michelle, additional, Cantor, Alan B., additional, Carcao, Manuel, additional, Carroll, Michael C., additional, Carty, Shannon A., additional, Castillo, Jorge J., additional, Chan, Anthony K.C., additional, Chapin, John, additional, Chiu, April, additional, Chute, John P., additional, Clark, David B., additional, Coates, Thomas D., additional, Cogle, Christopher R., additional, Connell, Nathan T., additional, Cooke, Elizabeth, additional, Cooley, Sarah, additional, Corradini, Paolo, additional, Creager, Mark A., additional, Creger, Richard J., additional, Cromwell, Caroline, additional, Crowther, Mark A., additional, Cushing, Melissa M., additional, Cutler, Corey, additional, Dang, Chi V., additional, Danial, Nika N., additional, Dave, Sandeep S., additional, DeCaprio, James A., additional, Dinauer, Mary C., additional, Dinner, Shira, additional, Diz-Küçükkaya, Reyhan, additional, Dodd, Roger Y., additional, Donato, Michele L., additional, Dorshkind, Kenneth, additional, Dotti, Gianpietro, additional, Dror, Yigal, additional, Dunleavy, Kieron, additional, Dvorak, Christopher C., additional, Ebert, Benjamin L., additional, Eck, Michael J., additional, Eikelboom, John W., additional, Epperla, Narendranath, additional, Ershler, William B., additional, Evans, William E., additional, Faderl, Stefan, additional, Ferrara, James L.M., additional, Filipovich, Alexandra Hult, additional, Fischer, Martin, additional, Fredenburgh, James C., additional, Friedman, Kenneth D., additional, Fuchs, Ephraim, additional, Fuller, Stephen J., additional, Gailani, David, additional, Galipeau, Jacques, additional, Gallagher, Patrick G., additional, Ganapathi, Karthik A., additional, Gardner, Lawrence B., additional, Gee, Adrian P., additional, Gerson, Stanton L., additional, Gertz, Morie A., additional, Giardina, Patricia J., additional, Gibson, Christopher J., additional, Golan, Karin, additional, Golub, Todd R., additional, Gonzales, Matthew J., additional, Gotlib, Jason, additional, Gottschalk, Stephen, additional, Grant, Marianne A., additional, Graubert, Timothy A., additional, Gregg, Xylina T., additional, Gribben, John G., additional, Gross, Dawn M., additional, Gruber, Tanja A., additional, Guitart, Joan, additional, Gurbuxani, Sandeep, additional, Gur-Cohen, Shiri, additional, Gutierrez, Alejandro, additional, Hamadani, Mehdi, additional, Hari, Parameswaran N., additional, Hartwig, John H., additional, Hayman, Suzanne R., additional, Hayward, Catherine P.M., additional, Hebbel, Robert P., additional, Heslop, Helen E., additional, Hillis, Christopher, additional, Hillyer, Christopher D., additional, Ho, Karin, additional, Hockenbery, David M., additional, Hoffman, Ronald, additional, Hogg, Kerstin E., additional, Holtan, Shernan G., additional, Horny, Hans-Peter, additional, Hsu, Yen-Michael S., additional, Hunter, Zachary R., additional, Huntington, James A., additional, Iancu-Rubin, Camelia, additional, Iqbal, Ali, additional, Isenman, David E., additional, Israels, Sara J., additional, Italiano, Joseph E., additional, Jaffe, Elaine S., additional, Jaffer, Iqbal H., additional, Jagannath, Sundar, additional, Jäger, Ulrich, additional, Jain, Nitin, additional, James, Paula, additional, Jeha, Sima, additional, Jordan, Michael B., additional, Josephson, Cassandra D., additional, Jung, Moonjung, additional, Kager, Leo, additional, Kambayashi, Taku, additional, Kanakry, Jennifer A., additional, Kantarjian, Hagop M., additional, Kaplan, Jason, additional, Karafin, Matthew S., additional, Karsan, Aly, additional, Kaufman, Randal J., additional, Kaufman, Richard M., additional, Keller, Frank G., additional, Kelly, Kara M., additional, Kessler, Craig M., additional, Key, Nigel S., additional, Keyzner, Alla, additional, Khandoga, Alexander G., additional, Khanna-Gupta, Arati, additional, Khatib-Massalha, Eman, additional, Klein, Harvey G., additional, Knoechel, Birgit, additional, Kollet, Orit, additional, Konkle, Barbara A., additional, Kontoyiannis, Dimitrios P., additional, Koreth, John, additional, Koretzky, Gary A., additional, Kotecha, Dipak, additional, Kremyanskaya, Marina, additional, Kumari, Anju, additional, Kuzel, Timothy M., additional, Küppers, Ralf, additional, Lacy, Martha Q., additional, Ladas, Elana, additional, Landier, Wendy, additional, Lapid, Kfir, additional, Lapidot, Tsvee, additional, Larson, Peter J., additional, Levi, Marcel, additional, Lewis, Russell E., additional, Liebman, Howard A., additional, Lillicrap, David, additional, Lim, Wendy, additional, Lin, Judith C., additional, Lindblad, Robert, additional, Lip, Gregory Y.H., additional, Little, Jane A., additional, Lohr, Jens G., additional, López, José A., additional, Luscinskas, Francis W., additional, Maciejewski, Jaroslaw P., additional, Majhail, Navneet S., additional, Manches, Olivier, additional, Mandle, Robert J., additional, Mann, Kenneth G., additional, Manno, Catherine S., additional, Marcogliese, Andrea N., additional, Mariani, Guglielmo, additional, Marincola, Francesco M., additional, Mascarenhas, John, additional, Massberg, Steffen, additional, McEver, Rodger P., additional, McGrath, Emer, additional, McKinney, Matthew S., additional, Mehta, Rohtesh S., additional, Mentzer, William C., additional, Merlini, Giampaolo, additional, Merryman, Reid, additional, Michel, Marc, additional, Migliaccio, Anna Rita, additional, Miller, Jeffrey S., additional, Mims, Martha P., additional, Mondoro, Traci Heath, additional, Moorehead, Paul, additional, Muniz, Luciana R., additional, Munshi, Nikhil C., additional, Najfeld, Vesna, additional, Nayak, Lalitha, additional, Nazy, Ishac, additional, Neff, Anne T., additional, Ness, Paul M., additional, Notarangelo, Luigi D., additional, O'Brien, Sarah H., additional, O'Connor, Owen A., additional, O'Donnell, Martin, additional, Olson, Amanda, additional, Orkin, Stuart H., additional, Pai, Menaka, additional, Pai, Sung-Yun, additional, Paidas, Michael, additional, Panch, Sandhya R., additional, Pande, Reena L., additional, Papayannopoulou, Thalia, additional, Parikh, Rahul, additional, Petersdorf, Effie W., additional, Peterson, Shane E., additional, Pittaluga, Stefania, additional, Ponce, Doris M., additional, Popolo, Laura, additional, Prchal, Josef T., additional, Pui, Ching-Hon, additional, Puigserver, Pere, additional, Rak, Janusz, additional, Ramos, Carlos A., additional, Rand, Jacob H., additional, Rand, Margaret L., additional, Rao, Dinesh S., additional, Ravandi, Farhad, additional, Rawlings, David J., additional, Reddy, Pavan, additional, Reding, Mark T., additional, Reiter, Andreas, additional, Rice, Lawrence, additional, Riese, Matthew J., additional, Ritchey, Arthur Kim, additional, Roberts, David J., additional, Roman, Elizabeth, additional, Rooney, Cliona M., additional, Rosen, Steven T., additional, Rosenthal, David S., additional, Rossmann, Marlies P., additional, Rot, Antal, additional, Rowley, Scott D., additional, Rubnitz, Jeffrey E., additional, Rydz, Natalia, additional, Salama, Mohamed E., additional, Sauk, Steven, additional, Saunthararajah, Yogen, additional, Savage, William, additional, Scadden, David, additional, Schaefer, Kristen G., additional, Schiffman, Fred, additional, Schneidewend, Robert, additional, Schrier, Stanley L., additional, Schuchman, Edward H., additional, Scullion, Bridget Fowler, additional, Selvaggi, Kathy J., additional, Senoo, Keitaro, additional, Shaheen, Montaser, additional, Shaz, Beth H., additional, Shelburne, Samuel A., additional, Shpall, Elizabeth J., additional, Shurin, Susan B., additional, Siegal, Deborah, additional, Silberstein, Leslie E., additional, Silberstein, Lev, additional, Silverstein, Roy L., additional, Sloan, Steven R., additional, Smith, Franklin O., additional, Smith, James W., additional, Smith, Katy, additional, Steensma, David P., additional, Steinberg, Martin H., additional, Stock, Wendy, additional, Storry, Jill R., additional, Stramer, Susan L., additional, Strauss, Ronald G., additional, Stroncek, David F., additional, Taylor, Justin, additional, Thota, Swapna, additional, Treon, Steven P., additional, Tulpule, Anil, additional, Valdes, Roberto Ferro, additional, Valent, Peter, additional, Vedantham, Suresh, additional, Vercellotti, Gregory M., additional, Verneris, Michael R., additional, Vichinsky, Elliott P., additional, von Andrian, Ulrich H., additional, Vose, Julie M., additional, Wagner, Andrew J., additional, Wang, Ena, additional, Wang, Jia-huai, additional, Warkentin, Theodore E., additional, Wasserstein, Melissa P., additional, Webster, Ann, additional, Weisdorf, Daniel J., additional, Weitz, Jeffrey I., additional, Westhoff, Connie M., additional, Wheeler, Allison P., additional, Widick, Page, additional, Wiley, James S., additional, William, Basem M., additional, Williams, David A., additional, Wilson, Wyndham H., additional, Wolfe, Joanne, additional, Wolgast, Lucia R., additional, Wood, Deborah, additional, Wu, Jennifer, additional, Yahalom, Joachim, additional, Yee, Donald L., additional, Younes, Anas, additional, Young, Neal S., additional, and Zeller, Michelle P., additional

Published
2018
Full Text
View/download PDF

49. Pathology and Abortion Rights Advocacy: Considerations in a Post-Roe World

Author

Jacobs, Jeremy W, primary, Adkins, Brian D, additional, Ahmad, Yembur, additional, Bahar, Burak, additional, Bulow, Uriel S, additional, Herrmann, Amanda C, additional, McDonald, Michelle M, additional, Jackson, Nicole R, additional, Mills, Anne M, additional, Owczarczyk, Anna B, additional, Shafi, Saba, additional, Shanes, Elisheva D, additional, Wang, Hannah, additional, Woo, Jennifer S, additional, Compton, Margaret L, additional, Johnson, Joyce E, additional, Wheeler, Allison P, additional, and Booth, Garrett S, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results